CN¥ 18.69
Key Takeaways
Risk factor
Very vulnerable to price shocks
Data is available to registered users only
Data is available to registered users only
Profitability factor
Undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Established in 1999, DaShenLin Pharmaceutical Group Co., Ltd. is a Chinese company based in Guangzhou. It operates across the pharmaceutical supply chain, engaging in the production, distribution, and direct sale of medicinal products throughout the country.
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITDA, unde
Data is available to registered users only
Target Price
The average target price of 603233.SS is 23.1 and suggests 23% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i
Data is available to registered users only